Brief Title
Survival Prolongation by Rationale Innovative Genomics
Protocol ID
NCT03386929
Brief Summary
Conditions: Non-small Cell Lung Cancer Metastatic; Non-small Cell Lung Cancer Stage III
Interventions: Drug: Avelumab; Drug: Axitinib; Drug: Palbociclib
Sponsors: Worldwide Innovative Networking Association; ARC Foundation for Cancer Research; Pfizer
Recruiting
Interventions: Drug: Avelumab; Drug: Axitinib; Drug: Palbociclib
Sponsors: Worldwide Innovative Networking Association; ARC Foundation for Cancer Research; Pfizer
Recruiting
Pub Date:
Friday, December 29, 2017 - 10:00am